Mortality trends of aortic stenosis in high-income countries from 2000 to 2020
Makoto Hibino(St. Michael's Hospital), Subodh Verma(St. Michael's Hospital), Guilherme F. Attizzani(Université Claude Bernard Lyon 1), Bobby Yanagawa(St. Michael's Hospital), Arjun Pandey(University of Ottawa), Marc Pelletier(University Hospitals of Cleveland), Dagfinn Aune(OsloMet – Oslo Metropolitan University), Hiromi Hibino(Imperial College London), Yoshiyuki Takami(Fujita Health University), Raj Verma(Royal College of Surgeons in Ireland), Deepak L. Bhatt(Mount Sinai Hospital)
Cited by 13
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k